ArrePath Secures £1M Grant for Antibiotics Against MDR Infections
19 Nov 2024 //
BUSINESSWIRE
Kevin Krause named President and CEO of ArrePath
19 Nov 2024 //
BUSINESSWIRE
ArrePath Appoints Michael Dudley, PharmD, Chairman, Board of Directors
24 Mar 2022 //
BUSINESSWIRE